These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32839684)

  • 21. Variability in Price of Generic Antipsychotic Medications at Community Pharmacies.
    Kriz CR; Nelson LA; Venkitachalam L; Allsworth JE; Cheng AL; Sommi RW
    Psychiatr Serv; 2020 Oct; 71(10):1005-1010. PubMed ID: 32576120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the Perception of Staff and Students of a University on Community Pharmacy Practice in Ipoh, Perak, Malaysia.
    Mathews A; Azad AK; Abbas SA; Bin Che Rose FZ; Helal Uddin ABM
    J Pharm Bioallied Sci; 2018; 10(4):226-231. PubMed ID: 30568380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community pharmacists' perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China.
    Song M; Ung CO; Lee VW; Hu Y; Zhao J; Li P; Hu H
    BMC Complement Altern Med; 2017 Jan; 17(1):9. PubMed ID: 28056935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fitness for purpose of pharmacy technician education and training: The case of Great Britain.
    Schafheutle EI; Jee SD; Willis SC
    Res Social Adm Pharm; 2017; 13(1):88-97. PubMed ID: 26827123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Raison D'être for the Community Pharmacy and the Community Pharmacist in Sweden: A Qualitative Interview Study.
    Wisell K; Sporrong SK
    Pharmacy (Basel); 2015 Dec; 4(1):. PubMed ID: 28970376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
    Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
    Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public Perceptions, Expectations, and Views of Community Pharmacy Practice in Kuwait.
    Awad AI; Al-Rasheedi A; Lemay J
    Med Princ Pract; 2017; 26(5):438-446. PubMed ID: 28934755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan.
    Hashmi FK; Hassali MA; Khalid A; Saleem F; Aljadhey H; Babar ZUD; Bashaar M
    BMC Health Serv Res; 2017 Jul; 17(1):500. PubMed ID: 28724411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness of osteoporosis risk assessment tools and screening recommendations among community pharmacists in Malaysia.
    Francis J; Toh LS; Sellappans R; Loo JSE
    Int J Clin Pharm; 2021 Jun; 43(3):604-612. PubMed ID: 33507463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generic medicine pricing in Europe: current issues and future perspective.
    Simoens S
    J Med Econ; 2008; 11(1):171-5. PubMed ID: 19450118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Health Policy; 2010 Jan; 94(1):68-75. PubMed ID: 19762106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan.
    Bashaar M; Hassali MA; Saleem F
    J Pharm Policy Pract; 2015; 8(1):16. PubMed ID: 26078869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Provision of travel medicine advice through community pharmacies: assessment of knowledge, attitudes and practices of pharmacists in Malaysia.
    Taha NA; See YL
    Int J Pharm Pract; 2016 Oct; 24(5):326-32. PubMed ID: 26914019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.